SITUATION REPORT YELLOW FEVER 5 MAY 2016 SUMMARY. SURVEILLANCE Angola

Similar documents
Outbreaks and Emergencies Bulletin

Emergency Plan of Action operation update

Zika Virus. History of Zika virus

msos Mobile SMS-based disease outbreak alert system

U.S. President s Malaria Initiative (PMI) Approach to Health Systems Strengthening

Regional partners meeting on Zika virus infection

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT

Ebola outbreak in West Africa What are the lessons learned from a coordinated network response in East Africa? CORDS HQ, Lyon 3 rd August 2014

Disease surveillance and outbreak prevention and control

Public Health Monitoring of Returning Travellers

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT UPDATE

EBOLA SITUATION REPORT

Responsibilities of Public Health Departments to Control Tuberculosis

WHO Regional Office for Europe update on avian influenza A (H7N9) virus

Africa-China trading relationship

Fact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus Assay. June 17, 2016

4

WHO: Ebola Response Roadmap Situation Report 1 October 2014

Planning for an Influenza Pandemic

ZIKA STRATEGIC RESPONSE FRAMEWORK & JOINT OPERATIONS PLAN JANUARY-JUNE 2016 FEB 2016

WHO in 60 years: a chronology of public health milestones

World Health Organization Department of Communicable Disease Surveillance and Response

HPAI Response HPAI Response Goals November 18, 2015

Cholera / Response / 1. Response to an Epidemic of Cholera

IMPLICATIONS OF OVERLAPPING MEMBERSHIP ON THE EXPECTED GAINS FROM ACCELERATED PROGRAM FOR ECONOMIC INTEGRATION (APEI)

Zika virus infection: guidance for primary care

Uganda: Ebola hemorrhagic fever

HIV/AIDS IN SUB-SAHARAN AFRICA: THE GROWING EPIDEMIC?

4A. Types of Laboratory Tests Available and Specimens Required. Three main types of laboratory tests are used for diagnosing CHIK: virus

Guidelines for Animal Disease Control

SOGC recommendation on ZIKA virus exposure for clinicians caring for pregnant women and those who intend to get pregnant

FEDERATIVE REPUBLIC OF BRAZIL Ministry of Agriculture, Livestock and Food Supply Secretariat of Animal and Plant Health and Inspection

Myth If someone with Ebola sneezes or sweats on you you will catch it

Enterprise Health Security Center Library Zika Virus: Employee Situational Update

Chapter 5. INFECTION CONTROL IN THE HEALTHCARE SETTING

RVF V F o c o cur u renc n e C ent n ral l A fric i a: D R C on o g n o Very few published data dealing with this region,

The economic and social impact of the Institute for Animal Health s work on Bluetongue disease (BTV-8)

Guidance for Public Health Interventions for Repatriation

Online Communicable Disease Reporting Handbook For Schools, Child-care Centers & Camps

Expanded Programme on Immunization

Dengue in the WHO european region

Crisis Management Centre - Animal Health (CMC-AH)

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases

UNICEF NIGERIA COUNTRY OFFICE Monthly Humanitarian Situation Report Date: 23 April, 2012

RABIES CASES IN BALI, INDONESIA: STRATEGIES AND CONSTRAINTS OF THE DISEASE. I Made Kardena Faculty of Veterinary Medicine Udayana University Bali

Zambia. Operational highlights. Working environment

I thank them for their openness, transparency, and willingness to work with WHO to address this newly emerging infection.

Sentinel Chicken Screening Here are the mosquito larvae! Ground Application Aerial Larvicide Applications

DISEASE EARLY WARNING SYSTEM -Plus (DEWS-Plus) Weekly Epidemiological Report 33

A HISTORY OF THE HIV/AIDS EPIDEMIC WITH EMPHASIS ON AFRICA *

EBOLA SITUATION REPORT

Algorithm for detecting Zika virus (ZIKV) 1

Seroprevalence and risk factors of Lassa fever infection in Nasarawa State, Nigeria 2013

GLOBAL EMPLOYEE BENEFITS PREPARING EXPATRIATES FOR THE AFRICAN EXPERIENCE

DEPARTMENT OF VETERINARY SERVICES MALAYSIA

consulting Company Profile Immigration, Relocation and Expat Support Services

Measles and rubella monitoring

CONGO (REPUBLIC OF THE)

Department of Epidemiological Surveillance and Intervention

Chapter 20: Analysis of Surveillance Data

The Rapidly Evolving Regulatory Landscape in Africa

HEALTH ALERT DUE TO AN INCREASE OF DENGUE IN THE REGION

POLIO ERADICATION AND ENDGAME STRATEGIC PLAN EXECUTIVE SUMMARY ADVANCES AGAINST POLIO IN 2012 ADVANCE COPY FOR MEDIA

Ebola Virus Disease Preparedness in Saskatchewan. Pacific Northwest Border Health Alliance Annual Workshop April 30, 2015

It takes a planet: global implications/consequences of local vaccine refusal

UNAIDS 2013 AIDS by the numbers

Florida Arbovirus Surveillance Week 25: June 19-25, 2016

Sudan Health Highlights A bi-monthly bulletin of WHO Sudan s Emergency Preparedness and Humanitarian Action (EHA) Weeks of June 2013

Outbreak of Legionnaires disease in a hotel in Calpe, Spain December 2011 January February 2012

BELIZE DOMINICAN REPUBLIC

Briefing Note on the ICGLR Regional Certification Mechanism

excerpted from Reducing Pandemic Risk, Promoting Global Health For the full report go to

Evaluation of the notifiable disease surveillance system in Gauteng Province, South Africa

The 2015 African Horse Sickness season: Report

Your Institution Logo Here. Your Division Logo Here. Audience Banner Here EBOLA. Location and Date Here

Swine Influenza Special Edition Newsletter

European Regulations for Animal Tracking

IN THE SENATE OF THE UNITED STATES , M. introduced the following bill; which was referred to the Committee on A BILL

Viral hepatitis. Report by the Secretariat

Rabies. A recurrent risk to the EU from dogs introduced from endemic countries (case studies)

MDG 4: Reduce Child Mortality

PROCEEDINGS KIGALI 3-4 NOVEMBRE,

Summary of GAVI Alliance Investments in Immunization Coverage Data Quality

Libreville Declaration on Health and Environment in Africa

DENGUE FEVER. This article was prepared to provide more information about Dengue Fever and Dengue Hemorrhagic Fever

Objectives of this session

Q&A on methodology on HIV estimates

LEADING DENGUE VACCINE CANDIDATE COULD CHANGE THE LIVES OF MILLIONS

EBOLA SITUATION REPORT INCORPORATING THE WHO ACTIVITY REPORT

UGANDA: Ebola Haemorrhagic Fever Epidemic

Global Influenza Surveillance Network (GISN) Activities in the Eastern Mediterranean Region

Seven Key Reasons Why immunization must remain a priority in the WHO European Region

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

Summary and Key Points

Central African Republic Country brief and funding request February 2015

ADVICE FOR EMPLOYEES Working in Angola

AV1300 STAFF INFLUENZA IMMUNIZATION AND EXCLUSION POLICY

Travel and transport risk assessment: Recommendations for public health authorities and transport sector

THE DENGUE STRATEGIC PLAN FOR THE ASIA PACIFIC REGION

Food safety threats international coordination

Transcription:

ZIKA VIRUS SITUATION REPORT YELLOW FEVER 5 MAY 2016 SUMMARY A yellow fever outbreak was detected in Angola late in December 2015 and confirmed by the Institut Pasteur Dakar (IP-D) on 20 January 2016. Subsequently, a rapid increase in the number of cases has been observed. As of 4 May 2016, Angola has reported 2149 suspected cases of yellow fever with 277 deaths. Among those cases, 661 have been laboratory confirmed. Despite vaccination campaigns in Luanda, there is still circulation of the virus in most districts of Luanda and in five additional provinces. Three countries have reported confirmed yellow fever cases exported from Angola: Democratic Republic of The Congo (DRC) (37 cases), Kenya (two cases) and People s Republic of China (11 cases). Namibia has also reported a suspect yellow fever case exported from Angola. This highlights the risk of international spread through non-immunised travellers. On 22 March 2016, the Ministry of Health of DRC notified human cases of yellow fever in connection with Angola. The Government officially declared the yellow fever outbreak on 23 April. As of 4 May, DRC has reported 5 probable cases and 39 laboratory confirmed cases: 37 imported from Angola, reported in Kongo central province and Kinshasa and two autochthonous cases in Ndjili, Kinshasa and Matadi, Kongo central province. The possibility of locally acquired infections is under investigation for at least 10 non-classified cases in both Kinshasa and Kongo central provinces. In Uganda, the Ministry of Health notified yellow fever cases in Masaka district on 9 April 2016. As of 4 May, seven yellow fever cases are laboratory confirmed in three districts: Masaka, Rukungiri and Kalangala. According to sequencing results, those clusters are not epidemiologically linked to Angola. The virus in Angola and DRC is largely concentrated in main cities and is likely to have been introduced to the cities following increased yellow fever viral circulation among monkeys in the forest. SURVEILLANCE Angola In Angola, from 5 December 2015 to 4 May 2016, the Ministry of Health has reported a total of 2149 suspect cases with 277 deaths and 661 laboratory confirmed cases. 70% of these cases are reported in Luanda province (Figure 1). There are confirmed cases in 13 of the 18 provinces and suspect cases are present in all provinces. Local transmission is still described in six provinces, in 14 districts, including Luanda. 1

The outbreak in Angola remains of high concern due to persistent local transmission in Luanda despite the fact that almost six million people have been vaccinated, local transmission has been reported in six provinces (urban areas and main ports) and there is a high risk of spread to neighbouring countries. The risk of establishment of local transmission in other provinces where no autochthonous cases are reported is high. DRC has reported cases imported from two provinces in Angola where no local transmission is currently reported (Cabinda and Zaire). Cabinda is an exclave and province of Angola and is separated from the rest of Angola by a narrow strip of territory belonging to the DRC and bounded on the north by the Republic of the Congo. The risk of effective local transmission is high due to expatriates working in this province. This poses also a further risk of transmission in DRC and Republic of the Congo. Figure 1. Distribution of yellow fever confirmed cases in Angola and DRC as of 4 May 2016 Democratic Republic of The Congo On 22 March 2016, the Ministry of Health of DRC, notified human cases of yellow fever in connection with Angola. The yellow fever outbreak was officially declared on 23 April. As of 4 May, DRC has reported 44 yellow fever cases linked to Angola, 39 of those are 2

laboratory confirmed cases with 37 imported from Angola, reported in Kongo central and Kinshasa provinces, and two autochthonous cases in Ndjili, Kinshasa and Matadi, Kongo central province. The possibility of locally acquired infections is under investigation for at least 10 nonclassified cases in both Kinshasa and Kongo central provinces. For a further five probable cases results are still pending at IP-D. Given the large Angolan community in Kinshasa, the presence and the activity of the Aedes mosquito, the potential establishment of local cycle of transmission in DRC in general and in the whole of Kinshasa in particular, the situation is of high concern and needs to be monitored with extreme attention. Uganda On 9 April 2016, Uganda notified WHO of yellow fever cases in the south-western district of Masaka. On 21 April, one yellow fever case was confirmed in the eastern district of Rukungiri. As of 4 May, 41 suspect cases of yellow fever cases have been reported in seven districts. Seven cases have been laboratory confirmed (five in Masaka, one in Rukungiri and one in Kalangala). According to available information, the clusters of yellow fever in Uganda are not linked. The sequencing results indicate high similarities with the virus which has caused the outbreak in 2010. In addition, these results show that these clusters are not epidemiologically linked to Angola. Other countries bordering Angola On 28 April the Ministry of Health of Namibia reported one suspect case of yellow fever, imported from Benguela, Angola. The case is a 27-year-old female who was hospitalized first in Benguela and then at the Engela district hospital in the Ohangwena region (near the border with Angola). Samples have been sent for diagnosis, confirmation is pending. No suspected cases of yellow fever have been reported in the Republic of the Congo or Zambia. However, Namibia and Zambia share a long and porous border with Angola and controlling population movements between the three countries will be challenging. Three countries have reported confirmed yellow fever cases exported from Angola: DRC (38 cases), Kenya (two cases) and People s Republic of China (11 cases). Namibia has also reported a suspect yellow fever case from Angola. This highlights the risk of international spread through non-immunised travellers. 3

Risk assessment The outbreak in Angola remains of high concern due to: Persistent local transmission in Luanda despite the fact that almost six million people have been vaccinated. Local transmission reported in six highly populated provinces including Luanda. High risk of spread to neighbouring countries. Confirmed cases have already travelled from Angola to People s Republic of China, DRC and Kenya. As the borders are porous with substantial crossborder social and economic activities, further transmission cannot be excluded. Viraemic patients travelling pose a risk for the establishment of local transmission especially in countries where adequate vectors and susceptible human populations are present. For DRC, a field investigation conducted in April concluded that there is a high risk of local transmission of yellow fever in the country. Given the limited availability of vaccines, the large Angolan community in Kinshasa, the porous border between Angola and DRC and the presence and the activity of the vector Aedes in the country, the situation needs to be monitored with extreme attention. RESPONSE Vaccinations campaigns started first in Luanda province at the beginning of February and mid-april in Benguela and Huambo. Data indicates insufficient vaccination coverage among the three provinces (Figure 2). DRC and Uganda are GAVI Alliance eligible countries thus the vaccination campaigns in these countries will be covered by GAVI Alliance. 1.7 million vaccines are to be delivered in Angola shortly and a further 700 000 have been requested to the International Coordinating Group (ICG). 2.2 million vaccines and ancillaries are to arrive in DRC by mid-may. International media attention to yellow fever has been minimal. However, Angola has issued press information related to control measures in place in country. Other coverage has focussed on ensuring vaccination related to travel and prevention of spread of disease. WHO briefed communication leadership across the UN related to communications issues and resources for joint coordinated response to inquiries about the outbreak. 4

Figure 2. Vaccination population coverage in Angola as of 4 May 2016 5